Moody’s assigns ‘A3’ rating to CareGroup’s bonds

Moody’s Investors Service has assigned an “A3” rating to Boston-based CareGroup’s proposed $231 million of Series I bonds, to be issued by the Massachusetts Development Finance Agency. Moody’s has also affirmed its “A3” rating on $517 million of rated debt.

Advertisement

The rating assignment and affirmation were based on several factors, including CareGroup’s large size, as well as its growing patient volumes and market share.

The rating also takes into account the organization’s relatively low leverage position and front loaded debt schedule that has contributed to a declining debt burden over the last several years, according to Moody’s.

Key credit challenges include CareGroup’s status as a confederate model with varying degrees of integration among the member hospitals, modest operating performance, and the likelihood of increased capital spending in coming years.

The outlook is stable, reflecting Moody’s expectation that CareGroup “will continue to generate modest operating surpluses and improve performance over weaker 2015 levels.”

 

More articles on finance and revenue cycle management:

Syncordia to begin RCM services for Mercy St. Vincent Medical Center: 4 things to know
How rural hospitals in Wyoming work together to remain strong
OhioHealth chooses Fidelity Investments as recordkeeping provider for retirement plans

 

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.